Heterogeneity-oriented multidisciplinary and super-minimally invasive precision treatment framework for locally advanced gastric cancer
World Journal of Translational Medicine · 28.11.2026 · 12 (4)
DOI: 10.5528/wjtm.123849 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Translational Medicine, online erschienen am 28.11.2026. Verfasst von Qian-Qian Chen und 2 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Locally advanced gastric cancer, defined here as cT3-T4a disease with or without regional lymph node involvement and without distant metastasis, is characterized by substantial spatial and clonal heterogeneity. Distinct hypoxic, proliferative, invasive, immune-evasive, and treatment-resistant subpopulations may coexist within the primary tumor, the serosal-peritoneal interface, and regional lymph nodes. Standard perioperative systemic therapy and gastrectomy with D2 lymphadenectomy remain the established curative-intent treatment for resectable locally advanced gastric cancer; however, a uniform stage-based strategy may not fully represent the biological complexity of these tumors. To this end, we refined the Heterogeneity-oriented multidisciplinary team planning and super minimally invasive precision resection concept as a hypothesis-driven treatment framework rather than a clinically validated alternative to standard surgery. The framework comprises preoperative probabilistic heterogeneity mapping, heterogeneity-focused multidisciplinary decision-making, anatomically appropriate local treatment using endoscopic, laparoscopic or combined approaches, explicit management of the serosal-peritoneal and regional lymph node compartments, and postoperative biomarker-informed and risk-informed therapy. The proposed functional zones are not fixed anatomical layers, and endoscopic super minimally invasive surgery alone is insufficient for cT3-T4a disease. In particular, cT4a serosal involvement belongs to a serosal-peritoneal interface zone that requires laparoscopic evaluation and oncological control, while regional nodal disease requires guideline-concordant lymph node management. The model currently lacks primary clinical data, and claims of lower morbidity or superior long-term outcomes are not supported. Future validation should entail radiologic and pathologic mapping studies, followed by prospective feasibility studies measuring technical success, R0 resection, serosal and nodal control, perioperative complications, functional preservation, recurrence and survival. Heterogeneity-oriented multidisciplinary team planning and super minimally invasive precision resection should therefore be viewed as a testable framework for selected patients and clinical trials, with oncological adequacy taking priority over organ preservation.
Zitieren
APA
Chen, Q., Zhou, J., & Linghu, E. (2026). Heterogeneity-oriented multidisciplinary and super-minimally invasive precision treatment framework for locally advanced gastric cancer. World Journal of Translational Medicine, 12(4). https://doi.org/10.5528/wjtm.123849
Vancouver
Chen Q, Zhou J, Linghu E. Heterogeneity-oriented multidisciplinary and super-minimally invasive precision treatment framework for locally advanced gastric cancer. World Journal of Translational Medicine. 2026;12(4). doi:10.5528/wjtm.123849
BibTeX
@article{Chen2026,
author = {Chen, Qian-Qian and Zhou, Jia-Yan and Linghu, En-Qiang},
title = {Heterogeneity-oriented multidisciplinary and super-minimally invasive precision treatment framework for locally advanced gastric cancer},
journal = {World Journal of Translational Medicine},
year = {2026},
volume = {12},
number = {4},
doi = {10.5528/wjtm.123849}
}
EUVIMED